Clinical Report: Discovery of the ferroptosis-related hub gene cDKN1A in RA

Overview

This study identifies the ferroptosis-related hub gene cDKN1A and its association with the immune microenvironment in rheumatoid arthritis (RA). Utilizing bioinformatics and experimental validation, the research highlights the role of ferroptosis in RA pathogenesis.

Background

Rheumatoid arthritis (RA) is a prevalent autoimmune disorder affecting approximately 1% of the global population, leading to significant joint impairment and disability. Current therapies do not adequately address the needs of about 40% of patients, necessitating further exploration of RA's underlying mechanisms.

Data Highlights

No numerical or trial data provided in the source material.

Key Findings

• Ferroptosis is implicated in the pathogenesis of rheumatoid arthritis.
• cDKN1A was identified as a hub gene related to ferroptosis in RA.
• Bioinformatics analysis utilized two RA microarray datasets from the GEO database.
• Machine learning techniques were employed to identify diagnostic biomarkers for RA.
• Correlation analysis was conducted between identified biomarkers and infiltrating immune cells.

Clinical Implications

The identification of cDKN1A as a ferroptosis-related hub gene may provide a target for further research in RA.

Conclusion

This study identifies cDKN1A in the context of ferroptosis in rheumatoid arthritis.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- Identification and experimental validation of CD74, PGLYRP1, and TXN as potential biomarkers in rheumatoid arthritis: an integrative bulk and ScRNA-seq study
2. Clinical Rheumatology, 2025 -- Investigation of Shared Genomic Features in Systemic Juvenile Idiopathic Arthritis and Kawasaki Disease
3. Frontiers in Immunology, 2026 -- The Potential Involvement of FABP4 in Rheumatoid Arthritis-Associated Osteoporosis: A Comprehensive Bioinformatics Analysis and Experimental Validation
4. Clinical Rheumatology, 2020 -- Altered microRNA Profiles in Families Affected by Rheumatoid Arthritis: A Study of Patients, Their First-Degree Relatives, and Healthy Controls
5. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
6. Inhibition of ferroptosis rescues M2 macrophages and alleviates arthritis by suppressing the HMGB1/TLR4/STAT3 axis in M1 macrophages - ScienceDirect
7. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
8. Inhibition of ferroptosis rescues M2 macrophages and alleviates arthritis by suppressing the HMGB1/TLR4/STAT3 axis in M1 macrophages - ScienceDirect